CYP2D6 polymorphism
|
disease |
|
Disease or Syndrome
|
7
|
5
|
0.100 |
None |
1.000 |
13 |
4
|
1998 |
2019 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4173
|
1142
|
0.100 |
None |
0.862 |
29 |
3
|
1990 |
2019 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
4081
|
1204
|
0.100 |
None |
0.857 |
28 |
3
|
1990 |
2019 |
Primary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
3894
|
981
|
0.100 |
None |
0.857 |
28 |
3
|
1990 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.926 |
27 |
3
|
1991 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.926 |
27 |
3
|
1991 |
2019 |
Agnosia for Pain
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
204
|
25
|
0.100 |
None |
0.875 |
16 |
3
|
2003 |
2019 |
Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
3397
|
1843
|
0.400 |
None |
0.909 |
33 |
2
|
1995 |
2019 |
CUI: |
C0030193 |
Disease: |
Pain
|
Pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
1554
|
196
|
0.100 |
None |
1.000 |
28 |
2
|
1995 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.200 |
None |
0.880 |
25 |
2
|
1994 |
2018 |
Drug-induced tardive dyskinesia
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
94
|
67
|
0.100 |
None |
0.900 |
20 |
2
|
1995 |
2019 |
Tardive Dyskinesia
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Disease or Syndrome
|
94
|
67
|
0.100 |
None |
0.895 |
19 |
2
|
1995 |
2019 |
Major Depressive Disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1236
|
1451
|
0.500 |
None |
1.000 |
12 |
2
|
2004 |
2019 |
Lupus Erythematosus, Systemic
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
1883
|
1172
|
0.050 |
None |
0.600 |
5 |
2
|
1998 |
2017 |
Intraocular pressure disorder
|
disease |
Eye Diseases
|
Disease or Syndrome
|
304
|
56
|
0.030 |
None |
0.667 |
3 |
2
|
2008 |
2010 |
Glaucoma, Primary Open Angle
|
disease |
Eye Diseases
|
Disease or Syndrome
|
383
|
222
|
0.020 |
None |
1.000 |
2 |
2
|
2009 |
2010 |
response to SSRI
|
phenotype |
|
Cell Function
|
28
|
53
|
0.100 |
None |
1.000 |
1 |
2
|
2014 |
2014 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.400 |
None |
0.940 |
117 |
1
|
1996 |
2020 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.400 |
None |
0.940 |
117 |
1
|
1996 |
2020 |
Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.400 |
None |
0.400 |
40 |
1
|
1994 |
2019 |
Congestive heart failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1760
|
165
|
0.070 |
None |
1.000 |
7 |
1
|
2004 |
2017 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.050 |
None |
1.000 |
5 |
1
|
2004 |
2018 |
Malignant Head and Neck Neoplasm
|
disease |
Neoplasms
|
Neoplastic Process
|
767
|
118
|
0.050 |
None |
0.800 |
5 |
1
|
1998 |
2014 |
Heart failure
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
1499
|
201
|
0.050 |
None |
1.000 |
5 |
1
|
2010 |
2017 |
Head and Neck Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
786
|
118
|
0.050 |
None |
0.800 |
5 |
1
|
1998 |
2014 |